Fabre-Kramer Pharmaceuticals, Inc., based in Houston, TX, is a renowned leader in the identification, development, and commercialization of psychotropic drugs aimed at treating psychiatric and neurologic disorders. With a robust pipeline of innovative medications such as EXXUA, FKB01MD, FKW00GA, FKF02SC, and FKK01PD, the company is dedicated to advancing mental health treatment.
Committed to supporting all stakeholders, Fabre-Kramer Pharmaceuticals encourages individuals with inquiries to connect with their team for further information and assistance. With a focus on research and collaboration, the company strives to make a positive impact in the field of mental health through cutting-edge pharmaceutical solutions.
Generated from the website